Zofran and Acidosis - respiratory for Girls aged 10-19 (a phase IV clinical study of FDA data)

Summary:

Acidosis - respiratory is found for girls aged 10-19 who take Zofran (ondansetron hydrochloride). This study is created by eHealthMe based on reports of 1,362 girls aged 10-19 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Zofran when people have Acidosis - respiratory
Top conditions
Top co-used drugs
Top other side effects

On Jul, 05, 2026

1,362 girls aged 10-19 reported to have side effects when taking Zofran.
Among them, 29 people (2.13%) have Acidosis - respiratory

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Acidosis - respiratory?

Acidosis - respiratory (malformations of the skull, face, hands and feet) is found to be associated with 2,929 drugs and 3,545 conditions by eHealthMe. Check the latest studies of Acidosis - respiratory.

Number of reports submitted per year:

Could Zofran cause Acidosis - respiratory in girls aged 10-19?

Time on Zofran when people have Acidosis - respiratory *

Severity of Acidosis - respiratory

n/a

How people recovered from Acidosis - respiratory

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

B Precursor Type Acute Leukaemia (lymphoid cancer): 9 people, 31.03%
Klebsiella Infection: 7 people, 24.14%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 13.79%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 6.90%
Ill-Defined Disorder: 2 people, 6.90%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 3.45%
Endocrine Neoplasm Malignant (cancerous tumour of endoglands): 1 person, 3.45%
Appetite Disorder (abnormal eating habits): 1 person, 3.45%
Blood Creatinine Increased: 1 person, 3.45%
Constipation: 1 person, 3.45%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Hypotension (abnormally low blood pressure): 14 people, 48.28%
Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 37.93%
Acidosis (build-up of carbon dioxide in the blood): 10 people, 34.48%
Cardiac Arrest: 9 people, 31.03%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 9 people, 31.03%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 9 people, 31.03%
Stomatitis (inflammation of mucous membrane of mouth): 9 people, 31.03%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 9 people, 31.03%
Encephalopathy (functioning of the brain is affected by some agent or condition): 9 people, 31.03%
Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 9 people, 31.03%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and have Acidosis - respiratory?

- Check whether Acidosis - respiratory is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Zofran and Acidosis - respiratory

How the study uses the data?

The study is based on (applicable) gender, age, ondansetron hydrochloride (the active ingredients of Zofran) and Zofran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.